Maintenance therapy for patients with acute myeloid leukemia, particularly those who are ineligible for transplant, can be critical to treatment outcomes and quality of life for patients. In this episode, CANCER BUZZ speaks with Thomas LeBlanc, MD, hematologic oncologist, associate professor of Medicine, and associate professor in Population Health Sciences at Duke Cancer Institute, about the importance of keeping patients with acute myeloid leukemia in first remission as long as possible through maintenance therapy.
“You have to be aware of the benefits of maintenance therapy…and for patients who are being considered for transplant but who do not end up getting a transplant, it should really be the default option that those patients receive a maintenance therapy.” –Thomas W. LeBlanc, MD
Guest:
Thomas W. LeBlanc, MD
Hematologic Oncologist,
Associate Professor of Medicine,
Associate Professor in Population Health Sciences
Duke Cancer Network, Duke Cancer Institute
Durham, North Carolina
This is the fourth and final episode of a four-part series developed in connection with the ACCC education program Achieving and Maintaining Better Outcomes for Patients with Acute Myeloid Leukemia. This episode was made possible with support by Bristol Myers-Squibb.
Additional Reading/Sources
Improving Care Delivery for Transplant-Ineligible Patients with AML
AML Care Coordination in the Community Setting [Video Podcast]
Critical Conversation Strategies for Patients with AML [Video Podcast]
Strategies to Addressing Disparities in Patients with AML [Video Podcast]
Shared Decision-making in Acute Myeloid Leukemia
Achieving and Maintaining Better Outcomes for Patients with AML
Talking about Acute Myeloid Leukemia (Cancer Support Community)
Shared Decision-making: Practical Implementation for the Oncology Team (ACCC)
Expanding the Role of Advanced Practitioners to Address the Care Gap
Liquid Biopsy: Cancer Detection & Future Synergies
Two ACCC Presidential Themes Converge at One Annual Meeting
The Promise of MRD Testing in Multiple Myeloma & CLL
State Advocacy Matters
Jack's Caregiver Coalition
Virtual Integrative Services
AMCCBS LIVE: Precision Medicine Reimbursement
AMCCBS LIVE: Care Measurement
AMCCBS LIVE: Cancer Moonshot
AMCCBS LIVE: Industry Reconfiguration Trends
Digital Patient Assistance Guide
Improving Pathology Reports
Developments in TIL Cell Therapy
The Business Case for Hiring Oncology Social Workers
Biomarker Testing Advocacy
Genetic Counseling Advocacy
Leading with Gratitude
QI in Advanced NSCLC
A New Deal for Cancer
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain